{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:02:37Z","timestamp":1783663357256,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.radonc.2025.110992","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:06:42Z","timestamp":1750360002000},"page":"110992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Local control assessment following SABR for lung metastases of colorectal cancer: A multicenter retrospective analysis"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3709-3074","authenticated-orcid":false,"given":"Robin","family":"Morcet-Delattre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efg","family":"Duverg\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-0029","authenticated-orcid":false,"given":"Vincent","family":"Bourbonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-6351","authenticated-orcid":false,"given":"Romuald","family":"Le Scodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-2879","authenticated-orcid":false,"given":"Yoann","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Argo-Leignel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Kinj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efg","family":"Vaugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110992_b0005","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/PPO.0000000000000434","article-title":"Definition, Biology, and history of Oligometastatic and Oligoprogressive Disease","volume":"26","author":"Foster","year":"2020","journal-title":"The Cancer Journal"},{"key":"10.1016\/j.radonc.2025.110992_b0020","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and uses of stereotactic body radiation therapy for oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2025.110992_b0025","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2025.110992_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0960-7404(01)00013-5","article-title":"The surgical management of pulmonary metastasis: current concepts","volume":"10","author":"Davidson","year":"2001","journal-title":"Surg Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0035","article-title":"The International Registry of Lung Metastases. long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. the International Registry of Lung Metastases","volume":"113","author":"Pastorino","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2025.110992_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2021.10.023","article-title":"A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: the LaIT-SABR study","volume":"166","author":"Nicosia","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0045","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1002\/cncr.26067","article-title":"A survey of stereotactic body radiotherapy use in the United States","volume":"117","author":"Pan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110992_b0050","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.21037\/jtd.2019.12.12","article-title":"A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases","volume":"11","author":"Cao","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2025.110992_b0055","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2015.04.004","article-title":"Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy","volume":"92","author":"Binkley","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2017.02.093","article-title":"Stereotactic ablative radiation therapy for pulmonary metastases: histology, dose, and indication matter","volume":"98","author":"Helou","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12885-019-5362-5","article-title":"The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases","volume":"19","author":"Klement","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.110992_b0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams\u00a0: Statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.110992_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109571","article-title":"Dose prescription and reporting in stereotactic body radiotherapy: a multi-institutional study","volume":"182","author":"Das","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejmp.2016.03.015","article-title":"Lung stereotactic ablative body radiotherapy: a large scale multi-institutional planning comparison for interpreting results of multi-institutional studies","volume":"32","author":"Giglioli","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2025.110992_b0085","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1120\/jacmp.v14i4.4270","article-title":"Evaluation of dose prediction error and optimization convergence error in four-dimensional inverse planning of robotic stereotactic lung radiotherapy","volume":"14","author":"Chan","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00066-014-0747-5","article-title":"Comparison of 3D and 4D Monte Carlo optimization in robotic tracking stereotactic body radiotherapy of lung cancer","volume":"191","author":"Chan","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.110992_b0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1120\/jacmp.v16i5.5397","article-title":"Combination effects of tissue heterogeneity and geometric targeting error in stereotactic body radiotherapy for lung cancer using CyberKnife","volume":"16","author":"Kang","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.radonc.2025.110992_b0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41562-017-0189-z","article-title":"Redefine statistical significance","volume":"2","author":"Benjamin","year":"2018","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.radonc.2025.110992_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-9473(02)00225-6","article-title":"On the exact distribution of maximally selected rank statistics","volume":"43","author":"Hothorn","year":"2002","journal-title":"Comput Stat Data Anal"},{"key":"10.1016\/j.radonc.2025.110992_b0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijrobp.2005.07.982","article-title":"Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer","volume":"64","author":"van Laarhoven","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0120","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818794936","article-title":"Stereotactic Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: a Systematic Review and Meta-Analysis","volume":"17","author":"Jingu","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.110992_b0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/COC.0000000000000864","article-title":"Local recurrence outcomes of colorectal cancer oligometastases treated with stereotactic ablative radiotherapy","volume":"44","author":"Benson","year":"2021","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.3495","article-title":"Individualized stereotactic ablative radiotherapy for lung tumors: the iSABR phase 2 nonrandomized controlled trial","author":"Gensheimer","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13014-014-0223-5","article-title":"GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms","volume":"9","author":"Lacornerie","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.radonc.2015.09.008","article-title":"Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy","volume":"118","author":"Guckenberger","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0145","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/JTO.0b013e318293dc45","article-title":"Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis","volume":"8","author":"Guckenberger","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0150","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00066-017-1151-8","article-title":"Planning benchmark study for SBRT of early stage NSCLC: results of the DEGRO working group stereotactic radiotherapy","volume":"193","author":"Moustakis","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.110992_b0155","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ijrobp.2016.01.065","article-title":"Planning Target volume D95 and mean dose should be considered for optimal local control for stereotactic ablative radiation therapy","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13014-016-0652-4","article-title":"Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases","volume":"11","author":"Andratschke","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00066-017-1204-z","article-title":"Breathing-motion-compensated robotic guided stereotactic body radiation therapy","volume":"194","author":"Stera","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.110992_b0170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lungcan.2021.05.016","article-title":"Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer","volume":"157","author":"Duverg\u00e9","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.110992_b0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2016.07.026","article-title":"Local control dependence on consecutive vs. nonconsecutive fractionation in lung stereotactic body radiation therapy","volume":"121","author":"Alite","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0180","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jamaoncol.2021.2939","article-title":"Single-fraction vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases (SAFRON II): the Trans Tasman radiation oncology group 13.01 phase 2 randomized clinical trial","volume":"7","author":"Siva","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijrobp.2020.03.005","article-title":"Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 individual treatments","volume":"107","author":"Klement","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110992_b0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2018.09.007","article-title":"Competing risks in survival data analysis","volume":"130","author":"Dutz","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0195","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/SLA.0b013e31826b4dcc","article-title":"Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases","volume":"256","author":"Andreou","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2025.110992_b0200","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s13046-019-1405-7","article-title":"The JAK2\/STAT3\/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance","volume":"38","author":"Park","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.radonc.2025.110992_b0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14740\/gr1062w","article-title":"Difference between left-sided and right-sided colorectal cancer: a focused review of literature","volume":"11","author":"Baran","year":"2018","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.radonc.2025.110992_b0210","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00432-020-03223-9","article-title":"Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases","volume":"146","author":"Nicosia","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110992_b0215","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200256","article-title":"A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study","volume":"93","author":"Claude","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.110992_b0220","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2007.03.046","article-title":"Moderately low alpha\/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy","volume":"69","author":"Suwinski","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:53Z","timestamp":1761128573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025044962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S0167814025044962"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110992","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local control assessment following SABR for lung metastases of colorectal cancer: A multicenter retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110992"}}